County employees who take popular GLP-1 medications for weight loss, such as Ozempic and Wegovy, will have to dig into their own pockets to continue using them next year after the county commission voted last week to end coverage for the drugs. All 4,000-plus employees will also be paying higher healthcare premiums, deductibles and copays, as the county tries to keep pace with ballooning healthcare costs. The popularity of GLP-1 drugs has explod…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.